Correspondence  |   June 2003
Gabapentin: The First Preemptive Anti-Hyperalgesic for Opioid Withdrawal Hyperalgesia?: In Reply
Author Notes
  • Departments of Anesthesiology and Pharmacology & Toxicology, Queen's University, Kingston, Ontario, Canada.
Article Information
Correspondence   |   June 2003
Gabapentin: The First Preemptive Anti-Hyperalgesic for Opioid Withdrawal Hyperalgesia?: In Reply
Anesthesiology 6 2003, Vol.98, 1521-1522. doi:
Anesthesiology 6 2003, Vol.98, 1521-1522. doi:
In Reply:—
The above letter responds to the provocative question of whether gabapentin is a “broad spectrum” analgesic 1 and appropriately points out that things are not quite so simple.
Gustorff et al.  postulate that the effects of gabapentin reported by Dirks et al.  2 are not due to antinociception but, rather, to the suppression of hyperalgesia caused by withdrawal from intraoperative opioids. This is a reasonable hypothesis; however, it should be noted that Fassoulaki et al.  recently observed similar reductions in pain and opioid consumption with gabapentin in patients who received no  intraoperative opioids. 3 Therefore, gabapentin's effects cannot be solely due to suppression of opioid withdrawal hyperalgesia.
Nevertheless, this raises questions central to understanding the modulation of pain by gabapentin. While Gustorff et al.  correctly indicate that postoperative pain is predominantly nociceptive, they fail to emphasize the importance of spinal sensitization, 4 which contributes to hyperalgesia and allodynia and which may be suppressed by gabapentin. Indeed, although gabapentin has little antinociceptive effect in the uninjured organism, it has been shown, in the absence of opioids, to reduce pain responses after surgical tissue injury. 5 
The latter comments by Gustorrf et al.  illustrate the complexities of interpreting gabapentin's effect when administered with opioids. Ethical conduct of most postoperative trials requires the provision of rescue analgesia, often in the form of patient-controlled analgesia with morphine, which necessitates the integration of pain measures with morphine consumption as co-relevant outcome measures. 6 Although trials have been equivocal thus far, 7,8 the possibility that mechanisms of opioid tolerance 9 contribute to postoperative hyperalgesia and increased opioid requirements may confound results of analgesic trials. Therefore, gabapentin trials involving concomitant morphine administration must be interpreted in light of a possible interaction between these drugs. In this regard, we have observed in the rat that gabapentin prevents the development of morphine tolerance and partially reverses established tolerance indicating that such an interaction indeed exists. 10 Thus, although follow-up studies will further characterize the role of gabapentin in postoperative pain, even more sophisticated strategies are needed to distinguish between its specific pharmacological effects (e.g.  , analgesia, antihyperalgesia, antiallodynia and reversal of opioid tolerance).
Gilron I: Is gabapentin a “Broad-spectrum” analgesic? A nesthesiology 2002; 97: 537–9Gilron, I
Dirks J, Fredensborg BB, Christensen D, Fomsgaard JS, Flyger H, Dahl JB: A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. A nesthesiology 2002; 97: 560–4Dirks, J Fredensborg, BB Christensen, D Fomsgaard, JS Flyger, H Dahl, JB
Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q: The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth Analg 2002; 95: 985–91Fassoulaki, A Patris, K Sarantopoulos, C Hogan, Q
Woolf CJ, Chong MS: Preemptive analgesia–treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 1993; 77: 362–79Woolf, CJ Chong, MS
Field MJ, Holloman EF, McCleary S, Hughes J, Singh L: Evaluation of gabapentin and S-(+)- 3- isobutylgaba in a rat model of postoperative pain. J Pharmacol Exp Ther 1997; 282: 1242–6Field, MJ Holloman, EF McCleary, S Hughes, J Singh, L
Silverman DG, O'Connor TZ, Brull SJ: Integrated assessment of pain scores and rescue morphine use during studies of analgesic efficacy. Anesth Analg 1993; 77: 168–70Silverman, DG O'Connor, TZ Brull, SJ
Cortinez LI, Brandes V, Munoz HR, Guerrero ME, Mur M: No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia. Br J Anaesth 2001; 87: 866–9Cortinez, LI Brandes, V Munoz, HR Guerrero, ME Mur, M
Guignard B, Bossard AE, Coste C, Sessler DI, Lebrault C, Alfonsi P, Fletcher D, Chauvin M: Acute opioid tolerance: Intraoperative remifentanil increases postoperative pain and morphine requirement. A nesthesiology 2000; 93: 409–17Guignard, B Bossard, AE Coste, C Sessler, DI Lebrault, C Alfonsi, P Fletcher, D Chauvin, M
Mayer DJ, Mao J, Holt J, Price DD: Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci USA 1999; 96: 7731–6Mayer, DJ Mao, J Holt, J Price, DD
Gilron I, Biederman J, Jhamandas K, Hong M: Gabapentin blocks, and reverses, antinociceptive morphine tolerance in the rat paw-pressure and tail-flick tests. A nesthesiology 2003; 98: 1288–92Gilron, I Biederman, J Jhamandas, K Hong, M